Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel for postoperative pain in maxillary orthognathic surgery
NCT06499181Phase 1Completed
- Sponsor
- Naval Medical Center San Diego
- Start
- Feb 2018
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Naval Medical Center San Diego. Primary endpoint: Differences in post-op opioid consumption at 7 days. Started Feb 2018; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06499181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06499181.